BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BlossomHill Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-74.68	-64.02	-36.4
Net Income	-71.09	-60.56	-30.7

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	116	136.68	100.15
Total Debt	23.02	22.4	0.53
Net Cash (Debt)	92.98	114.28	99.62
Net Cash Growth	-	14.72%	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-56.89	-46.93	-31.42
Capital Expenditures	-0.68	-1.07	-0.09
Free Cash Flow	-57.56	-47.99	-31.51
Free Cash Flow Growth	-	-	-